Selexipag
Who holds supplier records for Selexipag? 8 organisations hold a current record for Selexipag: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (6) and China (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Selexipag: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/selexipag
Reading the evidence
- 8 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
6 of the 7 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Selexipag expires 1 Jun 2037. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (8)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Selexipag. Country is the organisation's recorded country, not necessarily the manufacturing site.
- MAITHRI DRUGS PRIVATE LTDIndia Company GMP cert on recordActive DMF 36155, 32123, 33561 · latest filing Jul 2021
- HONOUR LAB LTDIndia Company GMP cert on recordActive DMF 33061, 42241 · latest filing May 2026
- Alembic Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 33974 · latest filing Jul 2019
- Apotex Pharmachem India Pvt. Ltd.IndiaActive DMF 33828 · latest filing May 2019
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaActive DMF 33947 · latest filing Jun 2019
- MSN Laboratories Private LimitedIndia Company GMP cert on recordActive DMF 39699 · latest filing Mar 2024
- SABA ILAC SANAYII VE TICARET ANONIM SIRKETIActive DMF 42564 · latest filing Sept 2025
- Zhejiang Huayi Pharmaceutical Co., Ltd.ChinaActive DMF 39287 · latest filing Dec 2023
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (25 listed products contain Selexipag). The latest listed patent expires 1 Jun 2037. The latest listed exclusivity runs to 23 Nov 2029. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Selexipag is an oral selective IP prostacyclin receptor agonist used in the treatment of pulmonary arterial hypertension (PAH). It acts by relaxing the muscles in the walls of blood vessels to reduce the elevated pulmonary blood pressure to normal levels.
Chemical identity
- IUPAC name
- 2-[4-[(5,6-diphenylpyrazin-2-yl)-propan-2-ylamino]butoxy]-N-methylsulfonylacetamide
- Canonical SMILES
- CC(C)N(CCCCOCC(=O)NS(=O)(=O)C)C1=CN=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3
- InChIKey
- QXWZQTURMXZVHJ-UHFFFAOYSA-N
- Synonyms
- Uptravi API, act-293987, ns-304, uptravi
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Prostacyclin Receptor Agonist
- Mechanism of action
- Prostacyclin Receptor Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Selexipag?
8 organisations hold an active US FDA Type II Drug Master File or a CEP for Selexipag: MAITHRI DRUGS PRIVATE LTD (India), HONOUR LAB LTD (India), Alembic Pharmaceuticals Limited (India), Apotex Pharmachem India Pvt. Ltd. (India), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), MSN Laboratories Private Limited (India), SABA ILAC SANAYII VE TICARET ANONIM SIRKETI and Zhejiang Huayi Pharmaceutical Co., Ltd. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Selexipag Drug Master Files are active?
MAITHRI DRUGS PRIVATE LTD (DMF 36155, 32123), HONOUR LAB LTD (DMF 33061, 42241), Alembic Pharmaceuticals Limited (DMF 33974), Apotex Pharmachem India Pvt. Ltd. (DMF 33828), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 33947), MSN Laboratories Private Limited (DMF 39699), SABA ILAC SANAYII VE TICARET ANONIM SIRKETI (DMF 42564) and Zhejiang Huayi Pharmaceutical Co., Ltd. (DMF 39287). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does the FDA Orange Book list patents for products containing Selexipag?
Yes. The latest patent listed for an approved US product containing Selexipag expires 1 Jun 2037, across 25 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Selexipag supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Selexipag?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.